Ajoey Abraham
Surgical · Houston, TXNPI 1992319784
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,093, 3.4 times the $324 reported in 2021.
Across 130 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$578
- Novo Nordisk$487
- AstraZeneca$460
- Lilly USA, LLC$180
- Renalytix AI, Inc.$148
- Viiv Healthcare Company$127
- plus $714 from 18 others
What the payments were for
- Food & beverage$2,65198%
- Education$432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $578 |
| Novo Nordisk | 27 | $487 |
| AstraZeneca | 15 | $460 |
| Lilly USA, LLC | 10 | $180 |
| Renalytix AI, Inc. | 6 | $148 |
| Viiv Healthcare Company | 5 | $127 |
| GSK | 5 | $85 |
| Bayer | 5 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Gilead | 3 | $54 |
| Medtronic | 2 | $50 |
| Shield Therapeutics Inc | 3 | $44 |
| Tempus AI, Inc | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Exact Sciences | 2 | $33 |
| Inspire Medical Systems, Inc. | 2 | $31 |
| Pfizer | 1 | $25 |
| Amgen | 1 | $17 |
| Tris Pharma Inc | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,694 in reported general payments places this provider in the 85th percentile of 804 surgical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nebivolol Hcl | 22 | $307 |
| Valsartan | 13 | $155 |
| Rosuvastatin Calcium | 12 | $89 |
| Metformin Hcl ErMetformin Hcl | 20 | $72 |
| Amlodipine Besylate | 18 | $37 |
| Clonidine Hcl | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other surgical in Houston
- Marilyn ShookHouston$46K
- John ChapmanHouston$15K
- Zeena PatelHouston$13K
- Lisa LauHouston$6K
- Paige WheatonHouston$5K
- Janelle JakobiHouston$5K
- Sana SiddiqiHouston$5K
- Angela LimmerHouston$5K
- Jacqueline Tavares-AlvaradoHouston$5K
- Tanner SteedHouston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.